HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Unexpected higher blood loss associated with higher dose ε-aminocaproic acid in pediatric scoliosis surgery.

Abstract
The purpose of this study was to determine if a higher dosing of ε-aminocaproic acid (EACA) is associated with less perioperative blood loss than a lower dose. A total of 74 patients having scoliosis surgery were analyzed. Of the 74 patients, 36 patients received EACA (10 mg/kg/h) and 38 patients received EACA (33 mg/kg/h). After controlling for key variables, an infusion of 33 mg/kg/h of EACA was associated with an increase in intraoperative blood loss of 8.1 ml/kg compared with an infusion of 10 mg/kg/h of EACA. A 33 mg/kg/h intraoperative infusion is associated with higher intraoperative blood loss than an infusion at 10 mg/kg/h.
AuthorsHumphrey Lam, Thomas Austin, Thanh Nguyen, Jeffrey Martus, Jonathan Schoenecker
JournalJournal of pediatric orthopedics. Part B (J Pediatr Orthop B) Vol. 28 Issue 1 Pg. 40-44 (Jan 2019) ISSN: 1473-5865 [Electronic] United States
PMID30199414 (Publication Type: Journal Article)
Chemical References
  • Antifibrinolytic Agents
  • Aminocaproic Acid
Topics
  • Adolescent
  • Aminocaproic Acid (administration & dosage, adverse effects)
  • Antifibrinolytic Agents (administration & dosage, adverse effects)
  • Blood Loss, Surgical
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Infusions, Intravenous
  • Male
  • Retrospective Studies
  • Scoliosis (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: